Obesity as a factor contributing to pathogenesis of skin diseases
AbstractBased on the cumulative research data on the effect of adipose tissue on regulatory processes, it can be defined as a "new organ" of the immune system. To date, it has been proven that the presence of overweight and obesity can contribute to worsening of symptoms, exacerbation of existing diseases and may also contribute to the development of new diseases. In fact, obesity is a systemic pathological process that has a negative impact on many organ systems and, in particular, on all skin structural elements. The most common skin diseases in obese patients are striae, acrochordons, plantar hyperkeratosis and acanthosis. This article presents an analysis of these and other skin pathologies, impact of diagnosed obesity on their development; an analysis of clinical cases is given and options for treating obesity as a factor aggravating course of skin diseases are represented.
Keywords:obesity, skin diseases, etiology, pathogenesis, treatment
Funding. The study had no sponsor support.
Conflict of interest. The authors declare no conflict of interest.
For citation: Taganov A.V., Tikhomirov T.A., Rozhdestvenskaya O.A., Zaslavsky D.V., Tamrazova O.B., Gureeva M.A. Obesity as a factor contributing to pathogenesis of skin diseases. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2021; 10 (4): 52-61. DOI: https://doi.org/10.33029/2304-9529-2021-10-4-52-61 (in Russian)
References
1. Andrianova O.L., Mirsaeva G. Kh., Fazlyeva R.M., Ibragimova L.A. The role of multifactorial approach to treament of obesity in females. Almanah kliničeskoj mediciny [Almanac of Clinical Medicine]. 2015; (S 1): 8–12. DOI: https://doi.org/10.18786/2072-0505-2015-1-8-12 (in Russian)
2. WHO official site. Obesity and overweight. 2016. Available at: https://www.who.int/end-childhood-obesity/publications/echo-report/ru/ (in Russian)
3. Vasilevsky D.I., Balandov S.G., Anisimova K.A., Davletbaeva L.I. Obesity – a current socially significant medical problem. Russian Biomedical Research. 2019; 4 (3): 29–33. (in Russian)
4. Ng M., Fleming T., Robinson M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 [published correction appears in Lancet. 2014; 384 (9945): 746]. Lancet. 2014; 384 (9945): 766–781. DOI: https://doi.org/10.1016/S0140-6736(14)60460-8
5. Tishkovskiy S.V., Nikonova L.V., Doroshkevich I.P. “Modern approaches to treatment of obesity”. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta [Journal of the Grodno State Medical University]. 2015; (2): 134–9. (in Russian)
6. Swinburn B.A., Sacks G., Lo S.K., Westerterp K.R., Rush E.C., Rosenbaum M., et al. Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr. 2009; 89 (6): 1723–8. DOI: https://doi.org/10.3945/ajcn.2008.27061 PMID: 19369382; PMCID: PMC 3738432.
7. Szosland D. Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease. Int J Occup Med Environ Health. 2010; 23 (3): 287-91. DOI: https://doi.org/10.2478/v10001-010-0032-5 PMID: 20934953
8. Dalantaeva N.S., Pigarova E.A., Dzeranova L.K. Central mechanisms regulating energy metabolism and sibutramine. Ozhirenie i metabolism [Obesity and Metabolism]. 2012; 9 (3): 33-36. DOI: https://doi.org/10.14341/2071-8713-4971 (in Russian)
9. Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell. 2014; 156 (1-2): 20-44. DOI: https://doi.org/10.1016/j.cell.2013.12.012 PMID: 24439368; PMCID: PMC 3934003.
10. Nakamura K., Fuster J.J., Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014; 63 (4): 250-9. DOI: https://doi.org/10.1016/jjjcc.2013.11.006 PMID: 24355497; PMCID: PMC 3989503
11. Brembilla N.C., Boehncke W.-H. Dermal adipocytes’ claim for fame in psoriasis. Exp Dermatol 2016, Epub ahead of print.
12. Schaffler A., Scholmerich J., Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C 1q/TNFs and CTRPs. Trends Immunol. 2007; 28 (9): 393-9. DOI: https://doi.org/10.1016/jTt.2007.07.003 PMID: 17681884.
13. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121 (6): 2094-101. DOI: https://doi.org/10.1172/JCI45887 PMID: 21633177; PMCID: PMC 3104761.
14. Barton M. Childhood obesity: a life-long health risk. Acta Pharmacol Sin. 2012; 33(2): 189-93. DOI: https://doi.org/10.1038/aps.2011.204 PMID: 22301858; PMCID: PMC 4010330.
15. Garcfa-Hidalgo L., Orozco-Topete R., Gonzalez-Barranco J., Villa A.R., Dalman J.J., Ortiz-Pedroza G. Dermatoses in 156 obese adults. Obes Res. 1999; 7 (3): 299-302. DOI: https://doi.Org/10.1002/j.1550-8528.1999.tb00410.x PMID: 10348502.
16. Nemchaninova O.B., Dolgikh M. Yu. Structure of dermatological pathology in children and adolescents with overweight and obesity. Journal of Siberian Medical Sciences. 2019; (2): 61-70. (in Russian)
17. Al-Mutairi N. Associated cutaneous diseases in obese adult patients: a prospective study from a skin referral care center. Med Princ Pract. 2011; 20 (3): 248-52. DOI: https://doi.org/10.1159/000323597 PMID: 21454995
18. Gorlanov I.A., Zaslavskiy D.V., Leina L.M., Milyavskaya I.R. Obesity related skin disorders. Vestnik dermatologii i venerologii [Bulletin of Dermatology and Venereology]. 2016; 92 (6): 20-6. DOI: https://doi.org/10.25208/0042-4609-2016-92-6-20-26 (in Russian)
19. Kovaleva O.A., Ambrosova T.N., Ascheulova T.V. Adipokines: biological, patho-physiological and metabolic effects. Vnutrennyaya meditsina [Internal Medicine]. 2009; 3: 15-23. (in Russian)
20. Hercogova J., Ricceri F., Tripo L., Lotti T., Prignano F. Psoriasis and body mass index. Dermatol Ther. 2010; 23 (2): 152-4. DOI: https://doi.org/10.1111/j.1529-8019.2010.01309.x PMID: 20415822.
21. Wolk K., Mallbris L., Larsson P., Rosenblad A., Vingard E., Stahle M. Excessive body weight and smoking associates with a high risk of on-set of plaque psoriasis. Acta Derm Venereol. 2009; 89 (5): 492-7. DOI: https://doi.org/10.2340/00015555-0711 PMID: 19734975.
22. Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005; 141: 1527-34.
23. Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B., Gelfand J.M. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
24. Setty A.R., Curhan G., Choi H.K. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med. 2007; 167 (15): 1670-5. DOI: https://doi.org/10.1001/archinte.167.15.1670 PMID: 17698691.
25. Paller A.S., Mercy K., Kwasny M.J., Choon S.E., Cordoro K.M., Girolomoni G., et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013; 149 (2): 166-76. DOI: https://doi.org/10.1001/jamader-matol.2013.1078 PMID: 23560297; PMCID: PMC 3624889.
26. Kumar S., Han J., Li T., Qureshi A.A. Obesity, waist circumference, weight change and the risk of psoriasis in US women. J Eur Acad Dermatology Venereol. 2013; 27 (10): 1293-8.
27. Johnston A., Arnadottir S., Gudjonsson J.E., Aphale A., Sigmars-dottir A.A., Gunnarsson S.I., et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008; 159 (2): 342-50. DOI: https://doi.org/10.1111/j.1365-2133.2008.08655.x PMID: 18547319; PMCID: PMC 2757771.
28. Bremmer S., Van Voorhees A.S., Hsu S., Korman N.J., Lebwohl M.G., Young M., et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010; 63 (6): 1058-69. DOI: https://doi.org/10.1016/jjaad.2009.09.053 PMID: 20692722.
29. Murray C.S., Canoy D., Buchan I., Woodcock A., Simpson A., Cus-tovic A. Body mass index in young children and allergic disease: gender differences in a longitudinal study. Clin Exp Allergy. 2011; 41 (1): 78-85. DOI: https://doi.org/10.1111/j.1365-2222.2010.03598.x PMID: 20718779.
30. Chen Y., Rennie D., Cormier Y., Dosman J. Association between obesity and atopy in adults. Int Arch Allergy Immunol. 2010; 153 (4): 372-7. DOI: https://doi.org/10.1159/000316348 PMID: 20559003.
31. Silverberg J.I., Kleiman E., Lev-Tov H., Silverberg N.B., Durkin H.G., Joks R., et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol. 2011; 127 (5): 1180-6. e1. DOI: https://doi.org/10.1016/jjaci.2011.01.063 PMID: 21411132.
32. Loffler H., Aramaki J.U., Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol. 2002; 8 (1): 19-22. DOI: https://doi.org/10.1046/j.0909-752x PMID: 12005116.
33. Boza J.C., Trindade E.N., Peruzzo J., Sachett L., Rech L., Cestari T.F. Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol. 2012; 26 (10): 1220-3. DOI: https://doi.org/10.1111/j.1468-3083.2011.04265.x PMID: 21929550.
34. Nino M., Franzese A., Ruggiero Perrino N., Balato N. The effect of obesity on skin dis-ease and epidermal permeability barrier status in children. Pediatr Dermatol. 2012; 29 (5): 567-70. DOI: https://doi.org/10.1111/j.1525-1470.2012.01738.x PMID: 22471938.
35. Deplewski D., Rosenfield R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999; 140: 4089-94.
36. Cappel M., Mauger D., Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005; 141: 333-8.
37. Shipman A.R., Millington G.W. Obesity and the skin. Br J Dermatol. 2011; 165 (4): 743 - 50. DOI: https://doi.org/10.111Vj.1365-2133.2011.10393.x PMID: 21564065
38. Birtane M., Tuna H. The evaluation of plantar pressure distribution in obese and non-obese adults. Clin Biomech (Bristol, Avon). 2004; 19 (10): 1055-9. DOI: https://doi.org/10.1016/j.clinbiomech.2004.07.008 PMID: 15531056.16
39. Garda Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol. 2002; 3 (7): 497-506. DOI: https://doi.org/10.2165/00128071-200203070-00006 PMID: 12180897
40. Scott T.E., LaMorte W.W., Gorin D.R., Menzoian J.O. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg. 1995; 22 (5): 622-8. DOI: https://doi.org/10.1016/s0741-5214(95)7 0 0 50-1 PMID: 7494366.
41. Iannuzzi A., Panico S., Ciardullo A.V., Bellati C., Cioffi V., Iannuzzo G., et al. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity. J Vasc Surg. 2002; 36 (5): 965-8.
42. van Rij A.M., De Alwis C.S., Jiang P., Christie R.A., Hill G.B., Dutton S.J., et al. Obesity and impaired venous function. Eur J Vasc Endovasc Surg. 2008; 35 (6): 739-44.
43. Arfvidsson B., Eklof B., Balfour J. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidly obese patients. Vasc Endo-vasc Surg. 2005; 39: 505-9.
44. Sugerman H., Windsor A., Bessos M., et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Int Med. 1997; 241: 71-9.
45. Hashimoto M., Akishita M., Eto M., Kozaki K., Ako J., Sugimoto N., et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord. 1998; 22 (5): 477-84. DOI: https://doi.org/10.1038/sj.ijo.0800620 PMID: 9622346.
46. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999 Sep; 23 (9): 936-42. DOI: 10.1038/sj.ijo.0801022 PMID: 10490799
47. Enser M., Avery N.C. Mechanical and chemical properties of the skin and its collagen from lean and obese-hyperglycaemic (ob/ob) mice. Diabetologia. 1984; 27: 44-9.
48. Goodson W.H. III, Hunt T.K. Wound collagen accumulation in obese hyperglycemic mice. Diabetes. 1986; 35: 491-5.
49. Torley D., Bellus G.A., Munro C.S. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002; 147 (6): 1096-101. DOI: https://doi.org/10.1046/j.1365-2133.2002.05150.x PMID: 12452857
50. Yosipovitch G., DeVore A., Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007; 56 (6): 901-16; quiz 917-20. DOI: https://doi.org/10.1016/j.jaad.2006.12.004 PMID: 17504714.
51. Hud J.A. Jr., Cohen J.B., Wagner J.M., Cruz P.D. Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol. 1992; 128 (7): 941-4. PMID: 1626961
52. Molochkov V.A., Korneva L.B, Sarskaya E.S., Shcherbakova E.O, Polyanskaya A.A., Nodelman E.K. Association of benign epithelial neoplasms with beta human papillomavirus. Almanah kliniceskoj mediciny [Almanac of Clinical Medicine], 2014; 34: 47-51. (in Russian)
53. Hsu H.S., Chen W., Chen S.C., Ko F.D. Colored striae in obese children and adolescents. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1996; 37 (5): 349-52. PMID: 8942028.
54. Simkin B., Arce R. Steroid excretion in obese patients with colored abdominal striae. N Engl J Med. 1962; 266: 1031-5.
55. Angeli A., Boccuzzi G., Frajria R., Bisbocci D. Adrenal gland function test in the differential diagnosis of sthenic obesity with pink striae. Folia Endocrinol. 1970; 23: 566-78.
56. Dupuy A., Benchikhi H., Roujeau J.C., Bernard P., Vaillant L., Chosidow O., et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999; 318: 1591-4.
57. Gallup D.G., Freedman M.A., Meguiar R.V., Freedman S.N., Nolan T.E. Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency. Am J Obstet Gynecol. 2002; 187: 305-10.
58. Instructions for use Reduxin Forte from 26.10.2021. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=14a6c131-20f6-42d5-a12d-5c795a70bc29&t= (in Russian)